Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-04-20 Sale | 2023-04-21 5:53 pm | Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer | 5,000 | $14.02 | $70,100 | 26,785 (Direct) | View |
2023-03-21 Sale | 2023-03-23 8:04 pm | Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer | 1,004 | $12.55 | $12,603 | 31,785 (Direct) | View |
2023-03-17 Sale | 2023-03-21 7:03 pm | Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer | 649 | $12.94 | $8,396 | 32,789 (Direct) | View |
2023-03-16 Sale | 2023-03-17 6:04 pm | Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer | 5,313 | $13.44 | $71,404 | 46,826 (Direct) | View |
2023-02-16 Sale | 2023-02-17 4:58 pm | Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer | 5,000 | $15.12 | $75,600 | 34,289 (Direct) | View |
2023-01-19 Sale | 2023-01-20 6:44 pm | Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer | 5,000 | $14.56 | $72,800 | 39,289 (Direct) | View |
2022-12-15 Sale | 2022-12-16 4:55 pm | Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer | 5,000 | $14.64 | $73,200 | 44,289 (Direct) | View |
2022-11-17 Sale | 2022-11-18 4:12 pm | Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer | 5,000 | $16.54 | $82,700 | 49,289 (Direct) | View |
2022-10-20 Sale | 2022-10-28 4:24 pm | Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer | 5,000 | $15.92 | $79,589 | 54,289 (Direct) | View |
2022-09-15 Sale | 2022-09-16 4:33 pm | Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer | 5,000 | $16.03 | $80,150 | 59,289 (Direct) | View |
2022-08-18 Sale | 2022-08-19 4:52 pm | Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer | 5,000 | $16.3 | $81,500 | 64,289 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-03-15 Exercise | 2023-03-17 6:04 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer | 4,462 | $0 | 46,826 (Direct) | View |
2023-03-08 Option Award | 2023-03-10 7:24 pm | N/A 2033-03-08 | Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer | 67,257 | $0 | 67,257 (Direct) | View |
2022-03-09 Option Award | 2022-03-11 4:04 pm | N/A 2032-03-08 | Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer | 78,696 | $0 | 78,696 (Direct) | View |
2021-01-07 Option Award | 2021-01-08 4:58 pm | N/A 2031-01-06 | Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer | 40,999 | $0 | 40,999 (Direct) | View |
Ownership | 2020-10-15 8:08 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer | 0 | $0 | 166,030 (Direct) | View |